Cancer patients, complementary medicine, and the hospital system
Year: 2018
Type: dissertation
Abstract: In this PhD thesis, I examine the tensions surrounding the use of complementary medicine (CM) in an Australian cancer hospital. In-depth, semi-structured interviews revealed that there was a significant disparity of understandings between cancer patients and their medical teams regarding the use of CM. I argue that these conflicting understandings of CM have arisen within a larger social and political context where competing discourses of biomedicine, CM, and consumerism are entangled with issues of power, scientific knowledge, and ideology. I utilised thematic analysis and applied theories of medical dominance, risk, institutional ideology, consumerism, medical pluralism, and the political features of knowledge to explore the tensions between cancer patients using CM and their medical teams. The medical teams perceived that cancer patients were using expensive and ineffective CM in a desperate, vulnerable hope for a cancer cure. They expressed that CM is unproven by science, ineffective for curing cancer and may be harmful to patients. Yet, the cancer patients I interviewed perceived CM to be low risk, inexpensive and safe. They were using CM as part of their general lifestyle and to help with the side effects of biomedical treatments. These patients were not looking for a cancer cure from CM but, rather, had their hopes in biomedicine for a cancer cure. I contend that the medical teams’ negative perceptions of CM are inherently biased by institutional ideological processes. These processes overestimate the risks of CM and reject CM a priori because of paradigmatic differences that place CM outside the positivist values of biomedicine. I further argue that biomedicine exerts ideological control over CM in the cancer hospital by asserting that biomedical scientific knowledge is superior to all other forms of health knowledge. This reveals the political features of knowledge and the way in which biomedicine has created specific hierarchies of knowledge associated with scientific medicine. Elite doctors have the power to establish the highest status, rank, and privileges for themselves in these hierarchies of knowledge within biomedical institutions. They also distribute moral rankings of knowledge, where scientific biomedicine is unquestionably regarded as ethical, legitimate, and proper; and CM is perceived to be untrustworthy, unreliable, and harmful. This epistemological authority of biomedicine strictly controls how healthcare practices are conducted in its institutions, and excludes competing paradigms such as CM. This functions to preserve the dominant biomedical hierarchy of knowledge at the hospital. However, this assertion of knowledge causes distress to cancer patients using CM who report that they feel angry, powerless, confused, and anxious in their negotiations with the cancer hospital regarding the use of CM. These resulting tensions are counter to health-professional and hospital policies on patient-centred care, patient autonomy, and respect for patients. They lead to poor communication, which can impact upon informed consent and patient safety if undisclosed CM interacts adversely with biomedical treatments for cancer. These tensions also highlight a range of issues concerning the role of consumers in healthcare, the integration of CM into the hospital system on an equitable basis, the wider political debate of medical pluralism, and the role of power and ideology in understanding the sources of conflict between cancer patients using CM and the hospital in which they are treated.
Author: Gregory Thomas Connolly
Institution: The University of Melbourne
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2896439281
